TechQuartier and Fraunhofer Venture collaborating on a Sports Track venture building program alongside Eintracht Frankfurt
BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
